BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4060187)

  • 1. Erythromycin estolate-induced toxicity in cultured rat hepatocytes.
    Sorensen EM; Acosta D
    Toxicol Lett; 1985 Sep; 27(1-3):73-82. PubMed ID: 4060187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of dantrolene sodium with erythromycin estolate using primary cultures of rat hepatocytes.
    Sorensen EM; Acosta D
    Drug Chem Toxicol; 1985; 8(4):219-37. PubMed ID: 4075997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin toxicity in primary cultures of rat hepatocytes.
    Villa P; Bégué JM; Guillouzo A
    Xenobiotica; 1985; 15(8-9):767-73. PubMed ID: 4072263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythromycin estolate vs. erythromycin base, surface excess properties and surface scanning changes in isolated liver cell systems.
    Dujovne CA; Salhab AS
    Pharmacology; 1980; 20(6):285-91. PubMed ID: 7403251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromycin estolate impairs the mitochondrial and microsomal calcium homeostasis: correlation with hepatotoxicity.
    Richelmi P; Baldi C; Manzo L; Berte F; Martino AP; Mirabelli F; Bellomo G
    Arch Toxicol Suppl; 1984; 7():298-302. PubMed ID: 6595996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic effects of erythromycin estolate and chlorpromazine on hepatocytes isolated from rats of varying ages: a brief note.
    Abernathy CO; Lukacs L; Zimmerman HJ
    Mech Ageing Dev; 1980 Jan; 12(1):1-6. PubMed ID: 7354660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat.
    Lu X; Tian Y; Lian X; Jin Y; Jin T; Zhao Q; Hu B; Shen X; Fan X
    Food Chem Toxicol; 2014 Mar; 65():343-55. PubMed ID: 24412560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of the toxicity of erythromycin estolate in the perfused rat liver by endotoxin.
    Gaeta GB; Adinolfi LE; Utili R; Tripodi MF; Abernathy CO
    Life Sci; 1986 Aug; 39(5):453-60. PubMed ID: 3526067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes.
    Villa P; Cova D; De Francesco L; Guaitani A; Palladini G; Perego R
    Toxicology; 1992; 73(2):179-89. PubMed ID: 1609428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of flavonoids on drug-induced hepatotoxicity in vitro.
    Davila JC; Lenherr A; Acosta D
    Toxicology; 1989 Aug; 57(3):267-86. PubMed ID: 2756528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in liver function produced by erythromycin estolate in isolated and perfused rat liver].
    Adinolfi L; Gaeta GB; Utili R
    Boll Soc Ital Biol Sper; 1980 Aug; 56(16):1621-5. PubMed ID: 7459082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats.
    Venkateswaran S; Pari L; Viswanathan P; Menon VP
    J Ethnopharmacol; 1997 Aug; 57(3):161-7. PubMed ID: 9292408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base.
    Villa P; Sassella D; Corada M; Bartosek I
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1541-6. PubMed ID: 3190183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric analysis of cultured hepatocytes exposed to benoxaprofen.
    Sorensen EM
    Toxicol Lett; 1986 Dec; 34(2-3):277-86. PubMed ID: 3798486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver.
    Gaeta GB; Utili R; Adinolfi LE; Abernathy CO; Giusti G
    Toxicol Appl Pharmacol; 1985 Sep; 80(2):185-92. PubMed ID: 2992120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative liver toxicity of various erythromycin derivatives in animals.
    Viluksela M; Hanhijärvi H; Husband RF; Kosma VM; Collan Y; Männistö PT
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of pretreatment with bacterial endotoxin on erythromycin estolate-induced cholestasis].
    Adinolfi L; Perna P; Gaeta GB; Utili R
    Boll Soc Ital Biol Sper; 1981 Apr; 57(8):900-3. PubMed ID: 7023509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of erythromycin derivatives on cultured rat hepatocytes.
    Villa P; Bégué JM; Guillouzo A
    Biochem Pharmacol; 1984 Dec; 33(24):4098-101. PubMed ID: 6508855
    [No Abstract]   [Full Text] [Related]  

  • 20. Erythromycin jaundice: diagnosis by an in vitro challenge test.
    Cooksley WG; Powell LW
    Aust N Z J Med; 1977 Jun; 7(3):291-3. PubMed ID: 269690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.